• FirefoxInstall the new Firefox »
  •  Dow Up 0.86% Nasdaq Up 0.90%

    Antares Pharma Inc. (ATRS)

    -NasdaqCM
    2.63 Up 0.02(0.77%) Mar 2, 4:00PM EST
    |Pre-Market : 2.61 Down 0.01 (0.38%) 8:07AM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:2.61
    Open:2.62
    Bid:2.61 x 4000
    Ask:2.94 x 2600
    1y Target Est:5.30
    Beta:2.12
    Earnings Date:Mar 11 - Mar 16 (Est.)
    Day's Range:2.60 - 2.66
    52wk Range:1.82 - 4.68
    Volume:604,524
    Avg Vol (3m):926,913
    Market Cap:346.33M
    P/E (ttm):N/A
    EPS (ttm):-0.24
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ATRS

    Comparison

    Symbol% ChgMkt Cap
    ATRSUp 0.77%346.33M
    BDXUp 0.90%28.56B
    BJCT 0.00%N/A

    Key Statistics

    Forward P/E (1 yr):263.00
    P/S (ttm):15.05
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.24
    Quarterly EPS Est (Dec-14) :-0.05
    Mean Recommendation*:1.3
    PEG Ratio (5 yr expected):-0.14

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Antares Pharma, Inc. operates as a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies worldwide. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback